- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 471/22 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups in which the condensed systems contains four or more hetero rings
Patent holdings for IPC class C07D 471/22
Total number of patents in this class: 784
10-year publication summary
|
41
|
50
|
35
|
54
|
47
|
51
|
57
|
63
|
79
|
47
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5815 |
34 |
| King Faisal University | 918 |
30 |
| Gilead Sciences, Inc. | 2032 |
22 |
| Intra-Cellular Therapies, Inc. | 410 |
14 |
| Boehringer Ingelheim International GmbH | 4642 |
13 |
| Sumitomo Chemical Company, Limited | 9043 |
13 |
| Arizona Board of Regents on behalf of Arizona State University | 2644 |
13 |
| Shionogi & Co., Ltd. | 852 |
13 |
| Incyte Corporation | 1022 |
12 |
| Demerx, Inc. | 75 |
11 |
| Merck Sharp & Dohme LLC | 3751 |
11 |
| Samsung Display Co., Ltd. | 34907 |
10 |
| Array BioPharma Inc. | 498 |
10 |
| FUJIFILM Corporation | 29437 |
9 |
| The University of Tokyo | 4189 |
9 |
| Janssen Pharmaceutica N.V. | 3394 |
8 |
| Capacitor Sciences Incorporated | 58 |
8 |
| Novartis AG | 10744 |
7 |
| BASF SE | 20940 |
7 |
| Abbvie Inc. | 1800 |
7 |
| Other owners | 523 |